Clinical Trial Update: A Phase Ib Expansion Study Investigating the Safety, Efficacy, and Pharmacokinetics of Intravenous CUDC-101 in Subjects With Advanced Head and Neck, Gastric, Breast, Liver and Non-small Cell Lung Cancer Tumors [Phase 1]

View source ↗

Summary

Phase Ib expansion study of intravenous CUDC-101 evaluating safety, efficacy, and pharmacokinetics in advanced head and neck, liver, breast, gastric, and non-sm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Gastric Cancer
• Head and Neck Cancer
• Liver Cancer
• Non-small Cell Lung Cancer

Drugs mentioned

• CUDC-101

Snippet

Sponsor: Curis, Inc. | Conditions: Head and Neck Cancer, Liver Cancer | Phase 1 | Status: COMPLETED | Results posted: 2015-10-16